- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06395207
A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra Leone
April 29, 2024 updated by: PATH
This is a three arm cluster randomized control trial to determine if proactive community case management (ProCCM) conducted over a short period of time improves care-seeking indicators for febrile illnesses in children in hard to reach (HTR) areas of Sierra Leone compared to integrated community case management (iCCM). The three arms include:
- Optimized standard of care for CCM plus ProCCM - ProCCM will be implemented for two months near the start of the transmission season, and the existing program will be supplemented to ensure that HTR CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed.
- Optimized standard of care- as in arm 1 without ProCCM
- Routine implementation (control) - no changes (business as usual) to iCCM, SBCC and stock management.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
9000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Annie Arnzen, MPH
- Phone Number: 978-806-5837
- Email: aarnzen@path.org
Study Contact Backup
- Name: Megan Littrell, PhD
- Email: mlittrell@path.org
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Household lives within the study cluster
- Head of household or a household member over the age of 18 provides verbal consent for the HTR CHW visit
- All available household members at the time of the HTR CHW visits are eligible to receive services
Exclusion Criteria:
- Household does not live within the study cluster
- Household does not provide consent for the study visit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Optimized standard of care for CCM plus ProCCM
ProCCM will be implemented for two months near the start of the transmission season, and the existing program will be supplemented to ensure that HTR CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed.
|
Community health workers conduct proactive visits to households in their community every two weeks for two months to screen for fever and test and treat febrile individuals for malaria.
|
|
Active Comparator: Standard of care
As in arm 1 without ProCCM
|
Ensure CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed in the national strategy.
|
|
No Intervention: Routine implementation (control)
No changes (business as usual) to iCCM, SBCC and stock management.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The proportion of children under five years of age with recent fever (within the past two weeks) who sought care from a CHW or public health facility on the same day or day after fever onset
Time Frame: Cross sectional collected immediately post-intervention and 5 months post-intervention
|
Changes in care seeking will be assessed through three cross-sectional surveys.
A baseline survey will be conducted prior to intervention implementation followed by a second survey at or near the end of the ProCCM intervention period and a final survey at the end of the malaria transmission season.
|
Cross sectional collected immediately post-intervention and 5 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost per additional fever case promptly seeking care at qualified provider
Time Frame: 5 months post-intervention
|
Using project records and information from the cross-sectional surveys, the cost of delivering ProCCM, incremental SBCC and stockout management interventions will be determined with the incremental number of fever cases receiving prompt management by a qualified provider as the denominator.
|
5 months post-intervention
|
|
Barriers and enablers of care-seeking behavior for febrile illness of people of all ages and how ProCCM impacts this behavior explored through focus groups
Time Frame: End of the malaria transmission season which will be 2 months post intervention
|
Focus group discussions will be held with community members post-intervention to assess barriers and enablers of care-seeking for febrile illness among people of all ages and how ProCCM impacts this behavior as reported by community members
|
End of the malaria transmission season which will be 2 months post intervention
|
|
Perceptions of the availability, cost, quality, and ease of seeking care for febrile illness explored through focus groups and in-depth interviews with community members.
Time Frame: End of the malaria transmission season which will be 2 months post intervention
|
Focus group discussions and in-depth interviews will be held with community members to explore their perception of the intervention and how it impacts their sense of the availability, cost, quality, and ease of seeking care for febrile illness.
|
End of the malaria transmission season which will be 2 months post intervention
|
|
Job satisfaction and perceived workload as described by CHWs during focus groups and interviews
Time Frame: End of the malaria transmission season which will be 2 months post intervention
|
Focus groups and in-depth interviews will be conducted with community health workers to explore their job satisfaction and perceived workload as it relates to the intervention.
|
End of the malaria transmission season which will be 2 months post intervention
|
|
Differences in touchpoints and connection between CHWs and health facility staff as described through qualitative analysis.
Time Frame: End of the malaria transmission season which will be 2 months post intervention
|
In-depth interviews will be conducted with health facility staff and peer supervisors to explore how the intervention influences their perceived linkages and touchpoints with CHWs.
|
End of the malaria transmission season which will be 2 months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 6, 2024
Primary Completion (Estimated)
March 30, 2025
Study Completion (Estimated)
March 30, 2025
Study Registration Dates
First Submitted
April 23, 2024
First Submitted That Met QC Criteria
April 29, 2024
First Posted (Actual)
May 2, 2024
Study Record Updates
Last Update Posted (Actual)
May 2, 2024
Last Update Submitted That Met QC Criteria
April 29, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- ProCCM V1 2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.